Citation Impact
Citing Papers
AKI and Long-Term Risk for Cardiovascular Events and Mortality
2016
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Risk Prediction of Contrast-Induced Nephropathy
2006
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
2009
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Acute kidney injury
2012 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Universal Definition of Myocardial Infarction
2007 Standout
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Pathology of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Lesions
2012
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome
2013
Brachytherapy: here today, gone tomorrow?
2005
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
2004
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Contrast-induced acute kidney injury and diabetic nephropathy
2010
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
2011
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial
2011
A Comparison of Contemporary Definitions of Contrast Nephropathy in Patients Undergoing Percutaneous Coronary Intervention and a Proposal for a Novel Nephropathy Grading System
2008
Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels
2007
Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
2011
Global epidemiology and outcomes of acute kidney injury
2018 Standout
Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy
2006
Prevention of contrast-induced nephropathy: a critical review
2007
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention
2003
The clinical and renal consequences of contrast-induced nephropathy
2006
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
2004 Standout
Coronary Artery Stents
2000
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study
2014
Renal failure after percutaneous coronary intervention is associated with high mortality
2005
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
2006 Standout
Predictors and Impact of Bleeding Complications in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction
2009
How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes?
2011
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Cardiorenal Syndrome
2008 Standout
Acute kidney injury
2021 Standout
Impact of acute renal failure following percutaneous coronary intervention on long-term mortality
2008
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
2011
Prophylaxis Strategies for Contrast-Induced Nephropathy
2006
Predictors of diffuse and aggressive intra-stent restenosis
2001
Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention
2014
The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction
2012
Peri-procedural myocardial injury: 2005 update
2005
Atherosclerosis
2019 Standout
The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting
2012
Third Universal Definition of Myocardial Infarction
2012 Standout
Interaction of Gender and Age on Post Cardiac Catheterization Contrast-Induced Acute Kidney Injury
2008
Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention
2011
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
2009
The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
The Reno-Protective Effect of Hydration With Sodium Bicarbonate Plus N-Acetylcysteine in Patients Undergoing Emergency Percutaneous Coronary Intervention
2007
Contrast-Induced Acute Kidney Injury
2008
Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries
1999
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Periprocedural Myocardial Infarction
2010
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts
2003
Antithrombotic Therapy in Patients With Chronic Kidney Disease
2012
Economic burden of contrast-induced nephropathy: implications for prevention strategies
2007
Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty
2000
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts
2002
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Minimizing the Risks of Anticoagulants and Platelet Inhibitors
2010
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality
2011
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
2010
A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
2010
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Late Coronary Occlusion After Intracoronary Brachytherapy
1999
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
Works of R. Mehran being referenced
Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting
2000
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy
2014
Intracoronary radiation for patients with refractory in-stent restenosis
1999
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
2009
Are we making progress with percutaneous saphenous vein graft treatment?
2001
Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure
2001
Intracoronary radiation therapy for patients with in-stent restenosis. Interim report from a randomized clinical study
1998
Does lesion length affect late outcome of patients with in-stent restenosis? Results of the multicenter laser angioplasty for stent restenosis (LARS) registry
1998
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention
2002
Mechanisms and results of additional stent implantation to treat focal in-stent restenosis
1998
Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions
2002
Lack of association of intermediate CPK-MB elevation and late mortality in patients treated with intracoronary stents
1998
Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty.
2000